Gene · 57697
Papers1,618
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,618
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Repair and Therapeutic Strategies in Cancer Stem Cells. | Cancers (Basel) | 2023 | 36980782 | PubTator, text mining | PubMed |
| Spectrum of High-Risk Mutations among Breast Cancer Patients Referred for Multigene Panel Testing in a Romanian Population. | Cancers (Basel) | 2023 | 36980780 | PubTator, text mining | PubMed |
| Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis. | Cancers (Basel) | 2023 | 36980738 | PubTator, text mining | PubMed |
| KNO1-mediated autophagic degradation of the Bloom syndrome complex component RMI1 promotes homologous recombination. | EMBO J | 2023 | 36970874 | PubTator, text mining | PubMed |
| Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases. | Front Oncol | 2023 | 36969007 | PubTator, text mining | PubMed |
| Maintenance of genome integrity by the late-acting cytoplasmic iron-sulfur assembly (CIA) complex. | Front Genet | 2023 | 36968611 | PubTator, text mining | PubMed |
| Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection. | Front Oncol | 2023 | 36959801 | PubTator, text mining | PubMed |
| New pathogenic germline variants identified in mesothelioma. | Lung Cancer | 2023 | 36944283 | PubTator, text mining | PubMed |
| Induction of the alternative lengthening of telomeres pathway by trapping of proteins on DNA. | Nucleic Acids Res | 2023 | 36940725 | PubTator, text mining | PubMed |
| Discovering cryptic splice mutations in cancers via a deep neural network framework. | NAR Cancer | 2023 | 36937541 | PubTator, text mining | PubMed |
| Early diagnosis of brain metastases using cerebrospinal fluid cell-free DNA-based breakpoint motif and mutational features in lung cancer. | Clin Transl Med | 2023 | 36929639 | PubTator, text mining | PubMed |
| Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma. | J Ovarian Res | 2023 | 36922847 | PubTator, text mining | PubMed |
| Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma. | Transl Androl Urol | 2023 | 36915884 | PubTator, text mining | PubMed |
| Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system. | Neurooncol Adv | 2023 | 36915613 | PubTator, text mining | PubMed |
| Hereditary cancer syndromes. | World J Clin Oncol | 2023 | 36908677 | PubTator, text mining | PubMed |
| Variant curation and interpretation in hereditary cancer genes: An institutional experience in Latin America. | Mol Genet Genomic Med | 2023 | 36905130 | PubTator, text mining | PubMed |
| Why Don't the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment. | Int J Mol Sci | 2023 | 36902456 | PubTator, text mining | PubMed |
| Selected Genetic Factors Associated with Primary Ovarian Insufficiency. | Int J Mol Sci | 2023 | 36901862 | PubTator, text mining | PubMed |
| DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy. | Cancers (Basel) | 2023 | 36900418 | PubTator, text mining | PubMed |
| Phase separation properties of RPA combine high-affinity ssDNA binding with dynamic condensate functions at telomeres. | Nat Struct Mol Biol | 2023 | 36894693 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57697/papers?page=12